Improving quality of life with pulmonary rehabilitation after pulmonary embolism
Official title: Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study
Run by University Hospital, Brest · NCT05015153 · Data updated 2026-11-12
This study is testing whether a structured pulmonary rehabilitation program can help adults who have had a pulmonary embolism feel better and improve their quality of life, even after taking blood thinners.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 112 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 6 sites (Brest, France and 5 other locations) |
| Status | Recruiting |
| Started | May 11, 2022 |
| Main results expected | February 25, 2027 |
| Study ends | February 11, 2028 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT05015153 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been treated with anticoagulants for pulmonary embolism and have specific quality of life impairments.
✕Probably not a fit
Patients with chronic respiratory conditions, severe cardiac insufficiency, or those unable to participate in rehabilitation due to physical or psychological constraints may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of pulmonary rehabilitation (PR) on patients who have experienced a pulmonary embolism (PE) and continue to suffer from dyspnea and reduced quality of life despite anticoagulation treatment. The intervention involves a structured PR program aimed at alleviating symptoms and enhancing overall well-being. Patients eligible for the study are those aged 18 and older who have been treated with anticoagulants for a specified duration and meet certain quality of life criteria. The study aims to provide evidence for the inclusion of PR in the therapeutic management of PE.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and reduce dyspnea in patients recovering from pulmonary embolism.
How similar studies have gone: While pulmonary rehabilitation is established for chronic respiratory diseases, its application post-pulmonary embolism is less common, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Patient treated with at least 3 months and up to 8 months of anticoagulation for symptomatic EP diagnosed according the ESC and ACCP guidelines. * Patients who have a PembQol score ≥ 10% and whose total scores for the subgroups Q7+8 (dyspnea) and Q4 (impact of daily life) are ≥ 10%. Exclusion Criteria: * Presence of CTEPH according to international guidelines * Patients treated for acute PE with anticoagulants for more than 8 months * Active cancer or in remission for less than two years * Dyspnea post - COVID due to parenchymal injuries * Post-COVID hyperventilation syndrome without pulmonary vascular perfusion sequelae. * Physical or psychological inability to undertake PR * Isolated or more distal segmental PE * Neuro-muscular disease with PR contraindication. * Cardiac insufficiency (unstable coronary artery disease) * Severe respiratory failure (long-term oxygen therapy, pulmonary hypertension) * Chronic dyspnea MMRC ≥ 2 before PE * Cardiac or respiratory rehabilitation in the previous year * Indication to urgent PR within 6 months at the time of inclusion * Life expectancy of less than 12 months * Inability to give consent * Patient under guardianship or curatorship * Patient deprived of liberty by an administrative or judicial decision * Patient has not social security affiliation or who don't beneficiary of such social security
Where it's running
-
CHU Brest
Brest, France, France Recruiting -
CHU Angers
Angers, France Recruiting -
CHU de Grenoble
Grenoble, France Recruiting -
CHBS Lorient
Lorient, France Recruiting -
Hegp (Ap-Hp)
Paris, France Recruiting -
CHU Saint-Etienne
Saint-Etienne, France Recruiting
Study contacts
- Study coordinator: Cécile TROMEUR, PH
- Email: cecile.tromeur@chu-brest.fr
- Phone: +33230337602
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization
This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk
This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.
-
Aspiration thrombectomy with the Symphony or Prodigy devices
This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.
-
PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.
This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.
-
Reperfusion options for acute pulmonary embolism
This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.